Drugs / [18F]ABBV-964i
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07348276 | Nov 2025 → Mar 2026 | progressive supranuclear palsy | Invicro | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]ABBV-964i | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07348276 ↗ |